Clinical Trials Logo

Inflammation clinical trials

View clinical trials related to Inflammation.

Filter by:

NCT ID: NCT03082729 Completed - Clinical trials for Cardiovascular Diseases

Vascular Inflammation in Psoriasis - Apremilast

VIP-A
Start date: April 24, 2017
Phase: Phase 4
Study type: Interventional

The purpose of the VIP-A study is to determine the effect of apremilast on aortic vascular inflammation, cardiometabolic biomarkers and body composition in patients with moderate-severe psoriasis.

NCT ID: NCT03081845 Completed - Gut Inflammation Clinical Trials

A1 Versus A2® Milk on the Gastrointestinal Physiology, Symptoms and Cognitive Behaviour for the Preschool Children

Start date: September 13, 2016
Phase: Phase 4
Study type: Interventional

This is a multiple-sites, double-blinded, randomized, controlled, parallel-designed, cross-over study among healthy preschoolers with 5 days consumption of A2 or A1 milk to compare the effects on gut inflammation, gastrointestinal symptoms and behavioral well-being.

NCT ID: NCT03077269 Active, not recruiting - Burns Clinical Trials

Understanding Coagulation and Inflammation in Burns

Start date: May 1, 2016
Phase:
Study type: Observational

The purpose of this study is to understand what happens to platelets and blood clotting factors in burn patients over time. This study will also examine the role of microparticles (MPs), nanoparticles (NPs), and micro RNA in burns. The investigators will be looking at small particles of cells that are released into the blood. These particles have been found to be important in a variety of different diseases. The investigators believe that MPs, NPs, and micro RNA may play a role in development of inflammation, and infections in burn patients. Thus, hopefully, this study will help understand how to minimize transfusions and bleeding in burn patients as well as how to reduce inflammation and infections in burn patients.

NCT ID: NCT03072199 Completed - Clinical trials for Myocardial Infarction

Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study

RITA-MI
Start date: June 1, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

RITA-MI aims to develop of a novel therapeutic concept to target the immune response in patients with acute myocardial infarction (MI) by depleting B-cells with a single injection of Rituximab which is approved for clinical use in cancer, autoimmune disease and inflammatory conditions. The goal is to re-purpose the drug, and translate the discovery into benefit for patients at high risk of cardiovascular events. Rituximab is expected to limit infarction size and improve the healing process, as complementary to other therapeutic strategies. The applicants intend to perform a clinical study in patients with acute myocardial infarction (MI). The objective is to find the optimal dose (lowest dose with highest biological efficacy and best safety profile) for peripheral blood B cell depletion during the first 6 days after injection, and selective molecular signatures associated with improved heart function through analysis of peripheral blood samples. The study rationale is to decrease the inflammatory reaction upon tissue necrosis following heart muscle ischemia.

NCT ID: NCT03069638 Completed - Clinical trials for Juvenile Idiopathic Arthritis

Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population

Start date: February 1, 2017
Phase: Phase 4
Study type: Interventional

The main objective of this study is to evaluate the effectivity of intranasal dexmedetomidine sedation during intra-articular injection therapy. Intranasal dexmedetomidine is compared with dinitrous oxide (N2O) which has already been proven safe and effective sedation method during painful procedures in pediatric patients. In earlier studies the median VAS during intra-articular corticosteroid injections with patients receiving nitrous oxide has been 3 (Uziel et al 2008). Study hypothesis is that with intranasal dexmedetomidine sedation the VAS pain levels will be 1 unit lower.

NCT ID: NCT03068442 Active, not recruiting - Inflammation Clinical Trials

The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition

Start date: February 17, 2017
Phase: Phase 2
Study type: Interventional

The invesigators propose a clinical study on patients undergoing carotid surgery (endarterectomy). The invesigators will determine carotid artery imaging features associated with (1) vessel wall inflammation, (2) downstream brain inflammation, and (3) cognitive benefit from surgery. This project will uncover links between inflamed carotid plaque and downstream brain inflammation. The invesigators will also determine carotid plaque imaging features predicting cognitive benefit from carotid surgery.

NCT ID: NCT03066791 Completed - Inflammation; Skin Clinical Trials

Turmeric and Curcumin on Sebum Production

Start date: November 30, 2016
Phase: N/A
Study type: Interventional

A noticeably increasing number of patients are asking for naturally based extracts and ingredients as supplementary dermatologic remedies. Patients are seeking natural and cost-effective skin care alternatives in place of prescription medications and procedures. Our study will evaluate the effects of oral curcumin and turmeric on sebum production in healthy subjects.

NCT ID: NCT03065504 Completed - Skin Inflammation Clinical Trials

Turmeric and Turmeric-containing Tablets and Sebum Production

Start date: November 2016
Phase: N/A
Study type: Interventional

A noticeably increasing number of patients are asking for naturally based extracts and ingredients as supplementary dermatologic remedies. Patients are seeking natural and cost-effective skin care alternatives in place of prescription medications and procedures. This study will isolate the effects of oral turmeric and assess a combination tablet that includes turmeric on sebum production in healthy subjects.

NCT ID: NCT03064932 Completed - Inflammation Clinical Trials

Effect of a Spice Blend on Cardiovascular Risk Factors and Diet Satisfaction

Start date: January 25, 2017
Phase: N/A
Study type: Interventional

This study is a randomized 3-period crossover, controlled feeding study designed to evaluate the effects of the most commonly consumed spices in the U.S. on CVD risk factors, inflammation & immune function, and diet satisfaction in participants at risk for CVD.

NCT ID: NCT03062748 Enrolling by invitation - Clinical trials for Obstructive Sleep Apnea

Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index

Start date: March 1, 2017
Phase:
Study type: Observational

The purpose of the study is to compare the relative contribution of systemic inflammation vs. Obstructive Sleep Apnea (OSA) severity (as measured by Apnea Hypopnea Index) in predicting cardiovascular and metabolic aberrations associated with mild-to-moderate obstructive sleep apnea.